The Hong Kong Association of the Pharmaceutical Industry

The Hong Kong Association of the Pharmaceutical Industry

Public Policy Offices

To drive the expedient access of innovative healthcare solutions for Hong Kong and Macau with high ethical standards.

About us

Formed in 1968, The Hong Kong Association of the Pharmaceutical Industry (HKAPI) has 32 full members and 4 affiliate members, including the world's top 20 companies engaged in the research and development of pharmaceuticals. Our member companies provide over 70 per cent of the prescription medicines in Hong Kong. Updating members with important information in the local pharmaceutical market, the Association aims to improve the overall well-being of Hong Kong people by making recommendations on healthcare policies, as well as the relationship among our member companies, the government and the community. The Association has actively participated in the events of the local health community and regularly presented its views to the public on different healthcare issues such as Voluntary Health Insurance Scheme, Pharmacy and Poisons (Amendment) Ordinance 2015 and various pharmaceutical regulations.

Website
http://www.hkapi.hk
Industry
Public Policy Offices
Company size
2-10 employees
Headquarters
Hong Kong
Type
Privately Held
Founded
1968
Specialties
Healthcare, Innovative healthcare Solution, People-Centre Care, Building Partnership, Industry Governance, Policy & Regulations, People Development, and R&D eco-system

Locations

  • Primary

    Room 906-7, 9/F, K. Wah Centre, 191 Java Road, North Point

    Hong Kong, HK

    Get directions

Employees at The Hong Kong Association of the Pharmaceutical Industry

Updates

  • The Hong Kong Association of the Pharmaceutical Industry (HKAPI) celebrated its 56th anniversary with an Annual Dinner on June 20th, 2024. The event brought together over 300 guests, including government officials, patient groups, academia, healthcare partners, NGOs, and industry members, to mark the collaborative journey towards healthcare excellence. The honourable guest, Prof. Lo Chung-Mau, Secretary for Health, commended HKAPI for its remarkable achievements over the past 56 years. He praised the association's commitment to advancing the pharmaceutical industry in Hong Kong and fostering collaborations that have significantly improved patient access to #innovative medicines. He underscored the government's ongoing efforts to develop Hong Kong as a biomedical hub and emphasized the industry's pivotal role in research and development. HKAPI President Ms. Shan Wu reflected on the association's 56-year history, noted the association's focus on serving patients and enabling Hong Kong to become a biomedical R&D hub. She expressed the importance of collaboration with different partners in Hong Kong and the GBA, emphasizing that it is through these partnerships that significant strides in healthcare progress have been made. Congratulations to HKAPI on 56 years of driving progress in the pharmaceutical sector and partnership in making Hong Kong a healthier place to live! #HKAPI #Pharmaceutical #Innovation #Collaboration #Biomedical #ClinicalTrials #HongKongHealthcare #ProgressThroughPartnership Read more: https://lnkd.in/gcTmfWWT

    • No alternative text description for this image
    • No alternative text description for this image
    • No alternative text description for this image
    • No alternative text description for this image
    • No alternative text description for this image
      +8
  • 📢 Exciting News! 🎉 We are thrilled to announce the formation of the HKAPI Board (2024-26) after Annual General Meeting held in Novotel Century Hong Kong, on April 9 2024. The newly appointed Board members are: President: Ms. Shan Wu Vice-President: Mr. Lawrence Wong Honorary Treasurer: Mr. Neo Lam Board Members (listed in alphabetical order of their surname) Mr. Derek Chang Ms. Kara Cheung Mr. Tony Cheng Ms. Diana Liu Mr. Carvin Man Mr. Christian Eberle Mr. SunKeun Huh Mr. James Zhu Congratulations to each of the newly appointed Board members! We express our sincere appreciation for their commitment and dedication to serving the HKAPI community. Their collective expertise and leadership will undoubtedly drive the advancement of the pharmaceutical industry in Hong Kong. Join us in extending our best wishes to the new HKAPI Board as they embark on their roles and responsibilities. #HKAPI #BoardFormation #Leadership #PharmaceuticalIndustry #HongKong

    • No alternative text description for this image
  • 📢 HKAPI Market Access Workshop Empowered Members in Navigating the Pharmaceutical Landscape! 🚀 We're excited to announce the success of the HKAPI Market Access Workshop! With nearly 200 attendees, it became our largest workshop in recent years. The diverse audience, including commercial, market access, medical, and regulatory professionals, created a dynamic learning environment. The workshop covered essential topics like Hong Kong drug registration, enlistment, tendering, reimbursement systems, and the use of big data in market access strategies. Attendees also learned about organizing patient support programs for enhanced affordability. Feedback was overwhelmingly positive, with attendees praising the valuable content and expertise of the speakers. At HKAPI, we're dedicated to our members' development and will continue organizing workshops on regulatory systems, ethics, primary healthcare, and opportunities in the Greater Bay Area. Thank you to all participants for making the Market Access Workshop a resounding success. Stay tuned for more exciting events! #HKAPI #MarketAccess #Pharmaceuticals #Healthcare #ProfessionalDevelopment Read more: https://lnkd.in/gb7P8pXe

    • No alternative text description for this image
    • No alternative text description for this image
    • No alternative text description for this image
    • No alternative text description for this image
    • No alternative text description for this image
      +8

Similar pages